Morin inhibits the activity of pancreatic lipase and adipogenesis
European Journal of Pharmacology · 2024
DOI: 10.1016/j.ejphar.2024.176705 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmacology, 2024. Verfasst von Venkateish V P und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, CSIR-Central Food Technological Research Institute, Mysore, 570020, India; Academy of Scientific and Innovative Research …. Hauptthemen laut MEDLINE: Adipogenesis, Flavonoids, Lipase, Molecular Docking Simulation. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India, Indian Council of Medical Research.
Abstract (Originalsprache)
Obesity is a major health issue that contributes significantly to increased mortality and morbidity worldwide. Obesity is caused by uncontrolled adipogenesis and lipogenesis, leading to several metabolism-associated problems. Pancreatic lipase, an enzyme that breaks down dietary lipids, is a prominent target for obesity. Orlistat, a known inhibitor of pancreatic lipase, is commonly employed for the management of obesity. However, its side effects, such as diarrhoea, nausea and bladder pain, urge to look out for safer alternatives. Morin is a pentahydroxyflavone, exerts a broad spectrum of pharmacological effects including antioxidant, anti-inflammatory, lipid lowering, anti-diabetic, anti-fibrotic, anti-cancer, etc. This study investigated the effect of morin on pancreatic lipase activity, in vitro and in vivo adipogenesis. Molecular docking and simulation studies showed morin to have a higher binding affinity towards pancreatic lipase compared with orlistat, which also inhibited its activity in vitro. Morin also reduced lipid droplet accretion and downregulated the expression of adipogenic and lipogenic genes. The acute oral toxicity of morin was determined in C57BL/6 mice, where morin did not show toxicity up to 2000 mg/kg body weight dose. Oral administration of morin to high fat diet fed mice reduced body weight, glucose and insulin levels. Also, the histopathological examination revealed reduction in adipocyte size and decreased mRNA expression of adipogenesis markers in white adipose tissue of morin administered group compared to high fat diet group. Overall, the results suggested morin inhibited pancreatic lipase activity, adipogenesis and further studies are warranted to explore its therapeutic potential for obesity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, CSIR-Central Food Technological Research Institute, Mysore, 570020, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
- Centre for Drug Discovery, Department of Biochemistry, Karpagam Academy of Higher Education, Coimbatore, 641021, Tamil Nadu, India.
- Department of Biochemistry, CSIR-Central Food Technological Research Institute, Mysore, 570020, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India. Electronic address: madanperumal@cf…
Förderung
- Council of Scientific and Industrial Research, India
- Indian Council of Medical Research
Zitieren
APA
V P, V., Rajamanikandan, S., & Perumal, M. K. (2024). Morin inhibits the activity of pancreatic lipase and adipogenesis. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2024.176705
Vancouver
V P V, Rajamanikandan S, Perumal MK. Morin inhibits the activity of pancreatic lipase and adipogenesis. European Journal of Pharmacology. 2024. doi:10.1016/j.ejphar.2024.176705
BibTeX
@article{VP2024,
author = {V P, Venkateish and Rajamanikandan, Sundarraj and Perumal, Madan Kumar},
title = {Morin inhibits the activity of pancreatic lipase and adipogenesis},
journal = {European Journal of Pharmacology},
year = {2024},
doi = {10.1016/j.ejphar.2024.176705}
}
EUVIMED